# ![@TheNorthStar5 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::855079501432270848.png) @TheNorthStar5 The North Star

The North Star posts on X about $xbi, $ibb, $actu, $rvmd the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::855079501432270848/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::855079501432270848/c:line/m:interactions.svg)

- [--] Week [-----] +122%
- [--] Month [-----] +21%
- [--] Months [------] -38%
- [--] Year [------] -8.90%

### Mentions: [--] [#](/creator/twitter::855079501432270848/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::855079501432270848/c:line/m:posts_active.svg)

- [--] Month [--] +8.30%
- [--] Months [--] -1.50%
- [--] Year [---] +49%

### Followers: [---] [#](/creator/twitter::855079501432270848/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::855079501432270848/c:line/m:followers.svg)

- [--] Week [---] +0.32%
- [--] Month [---] +0.96%
- [--] Months [---] -1.90%
- [--] Year [---] +2.30%

### CreatorRank: undefined [#](/creator/twitter::855079501432270848/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::855079501432270848/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  45% [finance](/list/finance)  7% [cryptocurrencies](/list/cryptocurrencies)  3% [technology brands](/list/technology-brands)  2% [exchanges](/list/exchanges)  1% [celebrities](/list/celebrities)  1% [nfl](/list/nfl)  1%

**Social topic influence**
[$xbi](/topic/$xbi) #31, [$ibb](/topic/$ibb) #7, [$actu](/topic/$actu) #3, [$rvmd](/topic/$rvmd) #9, [$kzia](/topic/$kzia) 24%, [$imrx](/topic/$imrx) #3, [$gild](/topic/$gild) #39, [$mrk](/topic/$mrk) #105, [$bmy](/topic/$bmy) #31, [ceo](/topic/ceo) 11%

**Top accounts mentioned or mentioned by**
[@maximusholla](/creator/undefined) [@actuatethera](/creator/undefined) [@kaziatx](/creator/undefined) [@biostocks](/creator/undefined) [@loubasenese](/creator/undefined) [@stevenacohen2](/creator/undefined) [@semodough](/creator/undefined) [@keithmcpherson](/creator/undefined) [@ripster47](/creator/undefined) [@bkfviking123](/creator/undefined) [@tommylugauer](/creator/undefined) [@benyoel](/creator/undefined) [@joealertz](/creator/undefined) [@alexand80831564](/creator/undefined) [@metsbatflip1](/creator/undefined) [@mets](/creator/undefined) [@dancarlson33](/creator/undefined) [@pharmdca](/creator/undefined) [@varroanalytics](/creator/undefined) [@amaymd](/creator/undefined)

**Top assets mentioned**
[Actuate Therapeutics, Inc. (ACTU)](/topic/$actu) [Revolution Medicines, Inc. (RVMD)](/topic/$rvmd) [Immuneering Corporation (IMRX)](/topic/$imrx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Adlai Nortye Ltd (ANL)](/topic/$anl) [Cypherpunk Technologies Inc. (CYPH)](/topic/$cyph) [Pfizer, Inc. (PFE)](/topic/$pfe) [Celcuity Inc. Common Stock (CELC)](/topic/$celc) [Gain Therapeutics, Inc. (GANX)](/topic/$ganx) [Immutable (IMX)](/topic/$imx) [SPDR S&P [---] ETF Trust (SPY)](/topic/$spy) [DIA (DIA)](/topic/$dia) [Vixco (VIX)](/topic/$vix) [Abivax SA (ABVX)](/topic/$abvx) [Zentalis Pharmaceuticals, LLC (ZNTL)](/topic/$zntl) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Celsius Holdings, Inc. Common Stock (CELH)](/topic/$celh) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [PVH Corp (PVH)](/topic/$pvh) [Kymera Therapeutics, Inc. (KYMR)](/topic/$kymr) [Litecoin (LTC)](/topic/$ltc) [Nuvectis Pharma, Inc.  (NVCT)](/topic/$nvct) [Incyte Corporation (INCY)](/topic/$incy) [Frontline Ltd. (FRO)](/topic/$fro) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Amer Sports, Inc. (AS)](/topic/$as) [AvePoint, Inc. Class A Common Stock (AVPT)](/topic/$avpt) [Ecolab Inc. (ECL)](/topic/$ecl) [Uber Technologies, Inc. (UBER)](/topic/$uber) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$ACTU @ActuateThera $IBB $XBI $RVMD Pipeline in a Molecule: The Biotech Rewriting Pancreatic Cancer Survival In this edition ofThe Upside Lou Basenese sits down with Dan Schmitt CEO ofActuate Therapeutics https://tbsupside.com/actu/ https://tbsupside.com/actu/"  
[X Link](https://x.com/TheNorthStar5/status/1996243438132515206)  2025-12-03T15:41Z [---] followers, [---] engagements


"@contrariansmind @DanCarlson33 $ACTU @ActuateThera $GILD $MRK @Pharmdca $ANL $APRE $GOSS $GANX @jfais20 Most biotech headlines miss the human part. A child with a normally fatal cancer had a complete tumor remission. Then it happened again. Both kids are still cancer-free 2+ years later. Watch my update interview with $ACTU CEO Dan Schmitt.👇 https://t.co/nb2stpSEvl Most biotech headlines miss the human part. A child with a normally fatal cancer had a complete tumor remission. Then it happened again. Both kids are still cancer-free 2+ years later. Watch my update interview with $ACTU CEO Dan"  
[X Link](https://x.com/TheNorthStar5/status/2017414146128531467)  2026-01-31T01:46Z [---] followers, [---] engagements


"@LouBasenese $ACTU Hello 5's again. Cheap stock @LouBasenese"  
[X Link](https://x.com/TheNorthStar5/status/2018369559116362156)  2026-02-02T17:02Z [---] followers, [--] engagements


"$APRE Aprea needs to shrink a tumor $IBB $XBI We were honored to have Aprea CEO Oren Gilad Ph.D. join @NIHDirector_Jay @RepBrianFitz @lou_kassa and other biotech leaders at @BiotechnologyPa for a roundtable discussion on the drug development and related research being done at PABC. https://t.co/3stybfBlb8 $APRE https://t.co/Sw8Mg0LiGA We were honored to have Aprea CEO Oren Gilad Ph.D. join @NIHDirector_Jay @RepBrianFitz @lou_kassa and other biotech leaders at @BiotechnologyPa for a roundtable discussion on the drug development and related research being done at PABC. https://t.co/3stybfBlb8"  
[X Link](https://x.com/anyuser/status/2009121757110608258)  2026-01-08T04:35Z [---] followers, [---] engagements


"$ACTU A @BioSpace feature by @AngelaGabriel explores how manufacturing planning is becoming central to biopharma strategyfrom provider selection to scale-up and regulatory readiness. The feature Includes perspective from @ActuateThera VP of CMC Rich Kenley. Read more: https://t.co/JEO57GPIki A @BioSpace feature by @AngelaGabriel explores how manufacturing planning is becoming central to biopharma strategyfrom provider selection to scale-up and regulatory readiness. The feature Includes perspective from @ActuateThera VP of CMC Rich Kenley. Read more: https://t.co/JEO57GPIki"  
[X Link](https://x.com/anyuser/status/2012259569796325379)  2026-01-16T20:24Z [---] followers, [--] engagements


"$ACTU $IBB $XBI $RVMD $IMRX @TargetedOnc coverage by @andrea_elea highlights the updated @ASCO GI findings from the Actuate-1801 study evaluating elraglusib plus gemcitabine/nab-paclitaxel in metastatic pancreatic ductal adenocarcinoma including a safety profile consistent with prior reports. For more: https://t.co/a8MBrDeBGx @TargetedOnc coverage by @andrea_elea highlights the updated @ASCO GI findings from the Actuate-1801 study evaluating elraglusib plus gemcitabine/nab-paclitaxel in metastatic pancreatic ductal adenocarcinoma including a safety profile consistent with prior reports. For"  
[X Link](https://x.com/anyuser/status/2013630622875435339)  2026-01-20T15:12Z [---] followers, [---] engagements


"Paired trade idea: Sell $RVMD buy $ACTU. Close the ridiculous gap. @ActuateThera has gorgeous impeccable mOS data. Thank me later $IBB $XBI"  
[X Link](https://x.com/anyuser/status/2015799920570044515)  2026-01-26T14:52Z [---] followers, [---] engagements


"$ACTU $RVMD $IMRX $IBB $XBI Most biotech headlines miss the human part. A child with a normally fatal cancer had a complete tumor remission. Then it happened again. Both kids are still cancer-free 2+ years later. Watch my update interview with $ACTU CEO Dan Schmitt.👇 https://t.co/nb2stpSEvl Most biotech headlines miss the human part. A child with a normally fatal cancer had a complete tumor remission. Then it happened again. Both kids are still cancer-free 2+ years later. Watch my update interview with $ACTU CEO Dan Schmitt.👇 https://t.co/nb2stpSEvl"  
[X Link](https://x.com/anyuser/status/2016928139130138851)  2026-01-29T17:35Z [---] followers, [---] engagements


"$ACTU $ANL $IMRX $RVMD $IBB $XBI .@LouBasenese and CEO Dan Schmitt discuss how $ACTU is targeting GSK-3 a kinase long viewed as undruggable in pancreatic cancer. After prior Big Pharma failures Actuate is showing clinical progress as elraglusib moves toward Phase [--]. #PancreaticCancer #Oncology #Biotech https://t.co/ShAtn2motK .@LouBasenese and CEO Dan Schmitt discuss how $ACTU is targeting GSK-3 a kinase long viewed as undruggable in pancreatic cancer. After prior Big Pharma failures Actuate is showing clinical progress as elraglusib moves toward Phase [--]. #PancreaticCancer #Oncology #Biotech"  
[X Link](https://x.com/anyuser/status/2019445794068172835)  2026-02-05T16:19Z [---] followers, [---] engagements


"Excellent snippet by $ACTU CEO Dan Schmidt and @LouBasenese . Stop being lazy and take a listen on this Elraglusib drug by @ActuateThera Wake up $IBB $XBI $RVMD $IMRX $ANL $BMY $MRK $PFE $GILD $RHHBY http://www.actuatetherapeutics.com .@LouBasenese and CEO Dan Schmitt discuss todays pancreatic cancer standard of care where aggressive chemotherapy offers limited survival gains and significant toxicity. $ACTU is pursuing a more targeted approach designed to disrupt key pathways cancers use to survive. https://t.co/1QXhGSuisp http://www.actuatetherapeutics.com .@LouBasenese and CEO Dan Schmitt"  
[X Link](https://x.com/anyuser/status/2020916254836470052)  2026-02-09T17:42Z [---] followers, [---] engagements


"$ACTU $IBB $XBI $RVMD $IMX $ANL $BMY $GILD $MRK @LouBasenese @Varro_Analytics @JohnCendpts @A_May_MD @RealAvidTrader @StevenACohen2 $KZIA $ACTU CEO Dan Schmitt talks with @LouBasenese about his journey from Big Pharma to earlier-stage biotech. From scaling billion-dollar franchises to advancing academic innovation out of Chicago Dan shares why early-stage biotech is where breakthroughs take shape. #Biotech https://t.co/69VrgdfMg4 $ACTU CEO Dan Schmitt talks with @LouBasenese about his journey from Big Pharma to earlier-stage biotech. From scaling billion-dollar franchises to advancing"  
[X Link](https://x.com/TheNorthStar5/status/2021674303302119812)  2026-02-11T19:54Z [---] followers, [---] engagements


"@gurgavin Non-event"  
[X Link](https://x.com/TheNorthStar5/status/1936914845758099878)  2025-06-22T22:31Z [---] followers, [--] engagements


"@GarysheffieldJr Sheff Jr has spoken"  
[X Link](https://x.com/TheNorthStar5/status/1937848844814815439)  2025-06-25T12:22Z [---] followers, [--] engagements


"@EarnToFly $4.7 million at $7 with "milestone" warrants(not [--] year warrants) that expire approx [--] months from now . Please correct"  
[X Link](https://x.com/TheNorthStar5/status/1938242300536148380)  2025-06-26T14:25Z [---] followers, [--] engagements


"$ACTU @ActuateThera @Maximus_Holla @preetkailon $IBB $XBI $RVMD $GILD $BMY $MRK $PFE @Pharmdca @BioStocks $ACTU https://t.co/RQxBGYlMU3 https://t.co/ArYvMdTAlh https://t.co/yv2OzoxGse $ACTU https://t.co/RQxBGYlMU3 https://t.co/ArYvMdTAlh https://t.co/yv2OzoxGse"  
[X Link](https://x.com/TheNorthStar5/status/1939734033283301395)  2025-06-30T17:13Z [---] followers, [---] engagements


"$IBB $XBI $RVMD $ACTU @ActuateThera $GILD $BMY $MRK $PFE 🚨📣 #insidertrading Fletcher Aaron G.L. bought $500K of $ACTU on 2025-06-27 Insider performance (2020-24): 🟢1d: 1% 🟢3d: 4% 🟢5d: 5% 🔴1m: -4% 🔴3m: -4% 🟢6m: 27% 🔴1y: -2% total trade: [--] $SPY $QQQ $DIA $VIX #stock #stockmarket #NASDAQ #NYSE #OTC 🚨📣 #insidertrading Fletcher Aaron G.L. bought $500K of $ACTU on 2025-06-27 Insider performance (2020-24): 🟢1d: 1% 🟢3d: 4% 🟢5d: 5% 🔴1m: -4% 🔴3m: -4% 🟢6m: 27% 🔴1y: -2% total trade: [--] $SPY $QQQ $DIA $VIX #stock #stockmarket #NASDAQ #NYSE #OTC"  
[X Link](https://x.com/TheNorthStar5/status/1939745078555140395)  2025-06-30T17:57Z [---] followers, [---] engagements


"@Maximus_Holla @haodongvli @BioStocks @PeterKolchinsky @princetongb @Maximus_Holla @Prof_Oak_ @ACInvestorBlog @joealertz @Varro_Analytics @Biotenic $QQQ $RUT @PanCAN Actuate President & CEO Daniel Schmitt joined host @irat1onal on @ProgressPotent1 to discuss the companys lead investigational drug elraglusib a novel GSK-3 inhibitor that targets cancer pathways linked to tumor growth and drug resistance. https://t.co/5eZ67PG5D3 $ACTU Actuate President & CEO Daniel Schmitt joined host @irat1onal on @ProgressPotent1 to discuss the companys lead investigational drug elraglusib a novel GSK-3"  
[X Link](https://x.com/TheNorthStar5/status/1942610358494998608)  2025-07-08T15:42Z [---] followers, [--] engagements


"$IBB $XBI $RVMD $QQQ $RUT $GILD $CRDF @aTyrNews $GILD $MRK $BMY @irat1onal "The benefit is clear in terms of long term benefit long term on drug and long term survival" said $ACTU CEO Daniel Schmitt. Listen to Mr. Schmitt describe the positive topline elraglusib Ph. [--] data in 1st-line treatment of metastatic #pancreaticcancer: https://t.co/dhyIPfJNwd "The benefit is clear in terms of long term benefit long term on drug and long term survival" said $ACTU CEO Daniel Schmitt. Listen to Mr. Schmitt describe the positive topline elraglusib Ph. [--] data in 1st-line treatment of metastatic"  
[X Link](https://x.com/TheNorthStar5/status/1943032613129838862)  2025-07-09T19:40Z [---] followers, [---] engagements


"$IBB $XBI @BioStocks $RVMD $GILD Actuate announced the end of the Ph [--] study evaluating elraglusib monotherapy or in combination with irinotecan irinotecan plus temozolomide or with cyclophosphamide plus topotecan in pediatric patients with refractory malignancies. https://t.co/qEZOIsWl6m $ACTU https://t.co/BBF04Bo9WK Actuate announced the end of the Ph [--] study evaluating elraglusib monotherapy or in combination with irinotecan irinotecan plus temozolomide or with cyclophosphamide plus topotecan in pediatric patients with refractory malignancies. https://t.co/qEZOIsWl6m $ACTU"  
[X Link](https://x.com/TheNorthStar5/status/1945833692217086024)  2025-07-17T13:11Z [---] followers, [---] engagements


"$GILD $BMY $MRK $RHHBY @Pharmdca $KZIA $RUT $ACTU $ABVX @megtirrell Actuate plans to further investigate elraglusibs ability to positively change patients potential for successful treatment in a Phase [--] trial in pediatric adolescent and adult patients with relapsed/refractory Ewing Sarcoma. https://t.co/qEZOIsWl6m $ACTU https://t.co/gjsYSxkXlw Actuate plans to further investigate elraglusibs ability to positively change patients potential for successful treatment in a Phase [--] trial in pediatric adolescent and adult patients with relapsed/refractory Ewing Sarcoma. https://t.co/qEZOIsWl6m $ACTU"  
[X Link](https://x.com/TheNorthStar5/status/1947985531985391667)  2025-07-23T11:41Z [---] followers, [---] engagements


"$APRE $ZNTL Does anybody know where the stock gods will take @ApreaTX should they shrink a tumor $IBB $XBI @Alexand80831564 What is the stock telling us @Maximus_Holla"  
[X Link](https://x.com/TheNorthStar5/status/1948000004062281791)  2025-07-23T12:39Z [---] followers, [---] engagements


"$KZIA Buy @KaziaTx Long and strong here under $10 for a parabolic move ST MT LT @Maximus_Holla @joealertz @bkfViking123 @RealAvidTrader @BioStocks Multiple news flows. very very tiny low floater. $13 mill MC should easily be $50- $75 mill MC $IBB $XBI Two 9% holders"  
[X Link](https://x.com/TheNorthStar5/status/1948050175701741653)  2025-07-23T15:58Z [---] followers, [---] engagements


"$KZIA $JAZZ @KaziaTx $IBB $XBI https://www.biospace.com/drug-development/glioblastoma-funding-rises-as-nonprofits-drive-interest-and-pharma-returns-to-the-table https://www.biospace.com/drug-development/glioblastoma-funding-rises-as-nonprofits-drive-interest-and-pharma-returns-to-the-table"  
[X Link](https://x.com/TheNorthStar5/status/1952388249294713067)  2025-08-04T15:16Z [---] followers, [---] engagements


"@Maximus_Holla @semodough $RVMD $ibb $XBI @joealertz Dr. Saeed study principal investigator comments on the launch of the Ph.1b trial of elraglusib in combination with retifanlimab and mFOLFIRINOX as a potentially synergistic immune-modulatory approach for patients with advanced #pancreaticcancer. https://t.co/Khrx0LILZY $ACTU https://t.co/Y6SCBg4tFY Dr. Saeed study principal investigator comments on the launch of the Ph.1b trial of elraglusib in combination with retifanlimab and mFOLFIRINOX as a potentially synergistic immune-modulatory approach for patients with advanced #pancreaticcancer."  
[X Link](https://x.com/TheNorthStar5/status/1953432613080735880)  2025-08-07T12:26Z [---] followers, [---] engagements


"@Maximus_Holla @semodough $RVMD $IMRX $IBB $XBI $ACTU $GILD $BMY @RNAiAnalyst @BioStocks We are confident that our recently completed financing provides sufficient capital to support our corporate initiatives into the second half of [----] and well through our upcoming anticipated interactions with the FDA and EMA" commented $ACTU CEO Daniel Schmitt. Learn more: https://t.co/NNOtZuWugO We are confident that our recently completed financing provides sufficient capital to support our corporate initiatives into the second half of [----] and well through our upcoming anticipated interactions with the"  
[X Link](https://x.com/TheNorthStar5/status/1970525175171997960)  2025-09-23T16:26Z [---] followers, [---] engagements


"@JonFromMaspeth It looks like Juan Soto will be be with his Mommy Monday morning buying a new [--] inch TV @tommylugauer @Ben_Yoel @metsbatflip1 @Mets @JonHeyman @Keith_McPherson @StevenACohen2 @metsbatflip1 @GarysheffieldJr @7BOOMERESIASON @SNY_Mets"  
[X Link](https://x.com/TheNorthStar5/status/1972130517941109055)  2025-09-28T02:45Z [---] followers, [--] engagements


"$1 bill later @JuanSoto25_ has officially been CANCELLED by the EVIL EMPIRE. @Keith_McPherson @JonFromMaspeth @tommylugauer @metsbatflip1 @Mets @SNY_Mets @joshhart @Ben_Yoel @BarstoolHubbs Lil bro eating pizzawatching TV tommorow night after cleaning out their lockers"  
[X Link](https://x.com/TheNorthStar5/status/1972636877925892570)  2025-09-29T12:17Z [---] followers, [--] engagements


"@tommylugauer @Ben_Yoel @Mets @SNYtv @TikiBarber @metsbatflip1 @StevenACohen2 @JonHeyman @7BOOMERESIASON @joshhart @JuanSoto25_ @MiamiMugz @Keith_McPherson So this is what they do with Citi Field during the playoffs. https://t.co/89Ap2LNBKS So this is what they do with Citi Field during the playoffs. https://t.co/89Ap2LNBKS"  
[X Link](https://x.com/TheNorthStar5/status/1973957733851549783)  2025-10-03T03:46Z [---] followers, [--] engagements


"@JoePompliano A spine-tingling epic call by Joe Davis on the shot heard round the world @GarysheffieldJr @BarstoolHubbs @stoolpresidente @Keith_McPherson @JonHeyman @JonFromMaspeth @JuanSoto25_ @Ben_Yoel @StevenACohen2 @tommylugauer @7BOOMERESIASON @MLB @FOXSports @YESNetwork @joshhart"  
[X Link](https://x.com/TheNorthStar5/status/1975933683568984336)  2025-10-08T14:37Z [---] followers, [---] engagements


"@27vladdyjr Hey Vladdy JR. can you say it louderTHE BLUE JAYS LOSE @davidortiz @NESN @FOXSports @AROD @derekjeter @BlueJays"  
[X Link](https://x.com/TheNorthStar5/status/1977894533607084203)  2025-10-14T00:29Z [---] followers, [---] engagements


"@Keith_McPherson THE BLUE JAYS LOSE"  
[X Link](https://x.com/TheNorthStar5/status/1977895971359949177)  2025-10-14T00:35Z [---] followers, [--] engagements


"$XBI $IBI $CRBP $AMRN $MJ TRUMP CONSIDERS EASING SOCIAL-DISTANCING GUIDELINES TO BOOST ECONOMY TRUMP CONSIDERS EASING SOCIAL-DISTANCING GUIDELINES TO BOOST ECONOMY"  
[X Link](https://x.com/TheNorthStar5/status/1242160281620447239)  2020-03-23T18:44Z [---] followers, [--] engagements


"$DRIO $PLAB $CFLD $CELH $Cfvi @BenRabizadeh @storytrading It sounds like the rumors of Big Ben's pain and margin call had some merits as Mr.@DarioHealth finally came clean tonight with a reality post of his recent stock market wreckage.The KOD has confessed his sins.Cathartic"  
[X Link](https://x.com/TheNorthStar5/status/1565523815207243777)  2022-09-02T02:15Z [---] followers, [--] engagements


"$GRCE- Grace Therapeutics New high-breaking out now $XBI $IBB @Maximus_Holla Low hanging fruit to $6 plus in late Jan/early Deb data catalyst. VERY VERY high POS @semodough"  
[X Link](https://x.com/TheNorthStar5/status/1864345496506044702)  2024-12-04T16:26Z [---] followers, [---] engagements


"$ACTU @ActuateThera $RVMD $QQQ $RUT Form [--] purchase at $7 on Actuate Updated Top Single Buy Stocks that individual officer or director bought significant large volume shares: $CDTX $KYMR $PVH $ACTU $LTC #AInvest #onlinetrading #wallstreet #tradingsignals #investinyou https://t.co/xH4MPngYW2 Updated Top Single Buy Stocks that individual officer or director bought significant large volume shares: $CDTX $KYMR $PVH $ACTU $LTC #AInvest #onlinetrading #wallstreet #tradingsignals #investinyou https://t.co/xH4MPngYW2"  
[X Link](https://x.com/TheNorthStar5/status/1940449765772439609)  2025-07-02T16:37Z [---] followers, [---] engagements


"$ACTU $RVMD $IMRX $IBB $XBI @Pharmdca @SheffStation $GILD $NVCT $MRK $BMY Actuate President & CEO Daniel Schmitt joined host @irat1onal on @ProgressPotent1 to discuss the companys lead investigational drug elraglusib a novel GSK-3 inhibitor that targets cancer pathways linked to tumor growth and drug resistance. https://t.co/5eZ67PG5D3 $ACTU Actuate President & CEO Daniel Schmitt joined host @irat1onal on @ProgressPotent1 to discuss the companys lead investigational drug elraglusib a novel GSK-3 inhibitor that targets cancer pathways linked to tumor growth and drug resistance."  
[X Link](https://x.com/TheNorthStar5/status/1942593567773306941)  2025-07-08T14:36Z [---] followers, [---] engagements


"Hey Dirk @RNAiAnalystplease take a look at $ACTU. Dan Schmidt of @ActuateThera is the real deal. A significantly de-risked story(see recent ASCO presentation) with 5X- 15X upside. Big Pharma exit. Listen here to start DD process https://actuatetherapeutics.com/ https://podcasts.apple.com/us/podcast/hope-in-hard-places-a-potential-new-option-for/id1511978581i=1000718849075 https://actuatetherapeutics.com/ https://podcasts.apple.com/us/podcast/hope-in-hard-places-a-potential-new-option-for/id1511978581i=1000718849075"  
[X Link](https://x.com/TheNorthStar5/status/1950979145237725507)  2025-07-31T17:57Z [---] followers, [---] engagements


"$ACTU $RVMD $IBB $XBI $INCY @Alexand80831564 $GILD $BMY $MRK @Maximus_Holla Actuate announced the initiation of the Ph. 1b trial of elraglusib in combination with Incytes PD-1 inhibitor retifanlimab and mFOLFIRINOX as frontline therapy in advanced pancreatic adenocarcinoma. The trial is being conducted in collaboration with @UPMCHillmanCC and @Incyte. https://t.co/roqmha9Kdh Actuate announced the initiation of the Ph. 1b trial of elraglusib in combination with Incytes PD-1 inhibitor retifanlimab and mFOLFIRINOX as frontline therapy in advanced pancreatic adenocarcinoma. The trial is being"  
[X Link](https://x.com/TheNorthStar5/status/1953080682453815340)  2025-08-06T13:08Z [---] followers, [---] engagements


"$ACTU @ActuateThera Are we in the incipient stages of a short squeeze in Actuate This is a tightly held security of long-term holders who are playing for an M & A deal with BP by end of [----] $IBB $XBI $RVMD Stellar mOS data at ASCO. Will they file NDA https://www.nasdaq.com/market-activity/stocks/actu/short-interest https://www.nasdaq.com/market-activity/stocks/actu/short-interest"  
[X Link](https://x.com/TheNorthStar5/status/1955629354429632999)  2025-08-13T13:55Z [---] followers, [---] engagements


"$ACTU @ActuateThera $IBB $XBI $RVMD $GILD $BMY $MRK @PanCAN $ACTU Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy https://t.co/0dW2fbNEyF $ACTU Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy https://t.co/0dW2fbNEyF"  
[X Link](https://x.com/TheNorthStar5/status/1960065291502625152)  2025-08-25T19:42Z [---] followers, [---] engagements


"$ACTU @ActuateThera Initiations 🔹 $ACTU Initiated at New Buy at B Riley; PT $20 🔹 $GOOGL Reinitiated at Buy at William O'Neil 🔹 $AS Reinitiated at Buy at William O'Neil 🔹 $AVPT Initiated at New Buy at B Riley; PT $25 🔹 $CDNA Initiated at New Market Perform at William Blair 🔹 $ECL Initiations 🔹 $ACTU Initiated at New Buy at B Riley; PT $20 🔹 $GOOGL Reinitiated at Buy at William O'Neil 🔹 $AS Reinitiated at Buy at William O'Neil 🔹 $AVPT Initiated at New Buy at B Riley; PT $25 🔹 $CDNA Initiated at New Market Perform at William Blair 🔹 $ECL"  
[X Link](https://x.com/TheNorthStar5/status/1960313312211595588)  2025-08-26T12:08Z [---] followers, [---] engagements


"$ACTU @ActuateThera FDA wants overall survival to be key in cancer trials- Bodes well for Actuate with their mOS data @ ASCO. Put it in the hands of Big Pharma for late [----] exit off accelerated approval 5-10X $RVMD $IBB $XBI $IMRX @PanCAN @A_May_MD https://www.fiercebiotech.com/cro/fda-recommends-all-cancer-clinical-trials-collect-overall-survival-datautm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceOncology&oly_enc_id=2104I6474078C5G"  
[X Link](https://x.com/TheNorthStar5/status/1960717080040222954)  2025-08-27T14:52Z [---] followers, [---] engagements


"$DRIO Dario's CEO @ErezRaphael should be sued for Financial Malpractice and the entire BOD at @DarioHealth should resign for gross negligence. NO position but a total epic clown show. Where are the regulator's @SECGov on this slow moving trainwreck INDICT and lock them up. $XBI"  
[X Link](https://x.com/TheNorthStar5/status/1967963573499650530)  2025-09-16T14:47Z [---] followers, [---] engagements


"$ACTU $RVMD $IMRX $IBB $XBI Dr. Saeed study principal investigator comments on the launch of the Ph.1b trial of elraglusib in combination with retifanlimab and mFOLFIRINOX as a potentially synergistic immune-modulatory approach for patients with advanced #pancreaticcancer. https://t.co/Khrx0LILZY $ACTU https://t.co/Y6SCBg4tFY Dr. Saeed study principal investigator comments on the launch of the Ph.1b trial of elraglusib in combination with retifanlimab and mFOLFIRINOX as a potentially synergistic immune-modulatory approach for patients with advanced #pancreaticcancer. https://t.co/Khrx0LILZY"  
[X Link](https://x.com/TheNorthStar5/status/1970588824569798965)  2025-09-23T20:39Z [---] followers, [---] engagements


"$KZIA $IBB $XBI @Alexand80831564 @Maximus_Holla @bkfViking123 @KaziaTx @ripster47 Please email: rep@maximgrp.com To receive: Maxim Group - Morning Minutes / Maxim Group - Equity Research Kazia Therapeutics Limited $KZIA covered by Naz Rahman CFA Jason McCarthy Ph.D Visit https://t.co/s7xLi34zcH for important disclosures. https://t.co/U9kz8sX1WL Please email: rep@maximgrp.com To receive: Maxim Group - Morning Minutes / Maxim Group - Equity Research Kazia Therapeutics Limited $KZIA covered by Naz Rahman CFA Jason McCarthy Ph.D Visit https://t.co/s7xLi34zcH for important disclosures."  
[X Link](https://x.com/TheNorthStar5/status/1973807391108891041)  2025-10-02T17:48Z [---] followers, [---] engagements


"@monaco_biotech This is significant company building development for @KaziaTx . Stock is a steal here now @Maximus_Holla @bkfViking123 $IBB $XBI $KZIA @ripster47 Low float you can't fall in the moat"  
[X Link](https://x.com/TheNorthStar5/status/1975543783199850554)  2025-10-07T12:48Z [---] followers, [---] engagements


"$KZIA @KaziaTx https://www.prnewswire.com/news-releases/kazia-therapeutics-announces-collaboration-and-in-licensing-agreement-for-first-in-class-pd-l1-protein-degrader-program-302576571.html https://www.prnewswire.com/news-releases/kazia-therapeutics-announces-collaboration-and-in-licensing-agreement-for-first-in-class-pd-l1-protein-degrader-program-302576571.html"  
[X Link](https://x.com/TheNorthStar5/status/1975545602550415730)  2025-10-07T12:55Z [---] followers, [---] engagements


"@BrickCenter_ Take an Uber next time Greek"  
[X Link](https://x.com/TheNorthStar5/status/1983349310566896098)  2025-10-29T01:44Z [---] followers, [--] engagements


"@YankeesSzn99 THE BLUE JAYS LOSE @27vladdyjr"  
[X Link](https://x.com/TheNorthStar5/status/1985181829251350966)  2025-11-03T03:06Z [---] followers, [--] engagements


"@monaco_biotech Just getting started. "Clinical data" abstract next week for San Antonio Breast Conference $KZIA. Don't be myopic"  
[X Link](https://x.com/TheNorthStar5/status/1990919771777298459)  2025-11-18T23:07Z [---] followers, [---] engagements


"@LauraLoomer @elonmusk The Crown Prince is a Bad Guy"  
[X Link](https://x.com/TheNorthStar5/status/1990954770438238560)  2025-11-19T01:26Z [---] followers, [--] engagements


"$kzia @Maximus_Holla Wake up call on @KaziaTx @BioStocks Load the PA before the ground rumbles @bkfViking123 SABCS abstracts post online Monday $CYPH @lady0fcrypt0s"  
[X Link](https://x.com/TheNorthStar5/status/1991885942827937869)  2025-11-21T15:06Z [---] followers, [---] engagements


"@Keith_McPherson Trade the Martian. He doesn't fit"  
[X Link](https://x.com/TheNorthStar5/status/1991913689281339723)  2025-11-21T16:56Z [---] followers, [--] engagements


"$KZIA @KaziaTx $IBB $XBI @Maximus_Holla https://www.prnewswire.com/news-releases/kazia-therapeutics-achieves-initial-icr-immune-complete-response-in-metastatic-tnbc-and-delivers-q4-business-update-with-breakthroughs-across-breast-cancer-immuno-oncology-and-gbm-regulatory-strategy-302618635.html https://www.prnewswire.com/news-releases/kazia-therapeutics-achieves-initial-icr-immune-complete-response-in-metastatic-tnbc-and-delivers-q4-business-update-with-breakthroughs-across-breast-cancer-immuno-oncology-and-gbm-regulatory-strategy-302618635.html"  
[X Link](https://x.com/TheNorthStar5/status/1991958519319519597)  2025-11-21T19:54Z [---] followers, [----] engagements


"$KZIA San Antonio Breast Conference abstracts post next week. Should reveal "clinical data" @Maximus_Holla Low float. Stock should be trading 3X from here w/o the upcoming squeeze then they probably finance and sock runs to $35 Don't miss it. Algos will turn on. Viral stupid $KZIA @KaziaTx $IBB $XBI @Maximus_Holla https://t.co/L9K4V4nqNi $KZIA @KaziaTx $IBB $XBI @Maximus_Holla https://t.co/L9K4V4nqNi"  
[X Link](https://x.com/TheNorthStar5/status/1991981453400588322)  2025-11-21T21:26Z [---] followers, [----] engagements


"$KZIA $IBB $XBI Found this piece online on @KaziaTx Take a listen to the brief podcast for a good backgrounder @DanCarlson33 @Maximus_Holla @monaco_biotech $CYPH https://www.crystalra.com/kazia-therapeutics @TheNorthStar5 @Maximus_Holla Spot on. $KZIA is poised for an explosive reset in valuation. $13M market cap is crazy. Going to be a massive short squeeze. https://www.crystalra.com/kazia-therapeutics @TheNorthStar5 @Maximus_Holla Spot on. $KZIA is poised for an explosive reset in valuation. $13M market cap is crazy. Going to be a massive short squeeze"  
[X Link](https://x.com/TheNorthStar5/status/1992255367779385773)  2025-11-22T15:34Z [---] followers, [---] engagements


"$KZIA @KaziaTx The SABCS abstracts should post on this site Monday after the close around 4:30 PM EST This could ignite the $KZIA shares on Tuesday $CYPH $IBB $XBI @Maximus_Holla @monaco_biotech @DanCarlson33 $IBB $XBI @bkfViking123 @lady0fcrypt0s https://sabcs.org/events/ https://sabcs.org/events/"  
[X Link](https://x.com/TheNorthStar5/status/1992356695067255088)  2025-11-22T22:17Z [---] followers, [---] engagements


"$KZIA Here's the new [--] page overview on the @KaziaTx story- good backgrounder $IBB $XBI There's a potential $1 billion value trapped in a $13 million vehicle- Stay tuned for more evidence @Maximus_Holla @lady0fcrypt0s @A_May_MD @bkfViking123 $IBB $XBI https://share.google/qch1WuvUMn2Dsqh0w https://share.google/qch1WuvUMn2Dsqh0w"  
[X Link](https://x.com/TheNorthStar5/status/1992359051221667840)  2025-11-22T22:26Z [---] followers, [---] engagements


"@preetkailon Put a little $KZIA in the PA @BioStocks @Maximus_Holla $IBB $XBI $CYPH"  
[X Link](https://x.com/TheNorthStar5/status/1993025293708099915)  2025-11-24T18:33Z [---] followers, [---] engagements


"$KZIA FMV on @KaziaTx is $30. TNBC data next week in San Antonio. What is the stock telling us @Maximus_Holla $IBB $XBI @ACInvestorBlog @ripster47 @A_May_MD"  
[X Link](https://x.com/TheNorthStar5/status/1996608212582220200)  2025-12-04T15:51Z [---] followers, [---] engagements


"@Alexand80831564 $XBI $IBB Check out my recent interview with $ACTU a potential game changer for pancreatic cancer patients. Over 500+ treated. Going into Ph [--] Check out my recent interview with $ACTU a potential game changer for pancreatic cancer patients. Over 500+ treated. Going into Ph 3"  
[X Link](https://x.com/TheNorthStar5/status/1998188541336014955)  2025-12-09T00:30Z [---] followers, [---] engagements


"@tommylugauer @Ben_Yoel @Mets @SNYtv @metsbatflip1 Mets fans mocked Yankees fans last year for trading for Devin Williams because of this moment. Now hes their closer they lost the best closer in the sport and they now dont have the guy who hit this home run. Funny. https://t.co/8PPAGrPQvn Mets fans mocked Yankees fans last year for trading for Devin Williams because of this moment. Now hes their closer they lost the best closer in the sport and they now dont have the guy who hit this home run. Funny. https://t.co/8PPAGrPQvn"  
[X Link](https://x.com/TheNorthStar5/status/1998860721644564735)  2025-12-10T21:01Z [---] followers, [--] engagements


"@SNYtv @StevenACohen2 @WFAN660 @Mets @metsbatflip1 @Ben_Yoel @tommylugauer @HowieRose @RealMichaelKay @EvanRobertsWFAN @Joelsherman1 @JennSalerno310 @JonFromMaspeth @Keith_McPherson Let's call a spade a spade. Juan Soto aka the billion dollar man "stole the payroll""  
[X Link](https://x.com/TheNorthStar5/status/1999132084644831273)  2025-12-11T15:00Z [---] followers, [--] engagements


"@BarstoolHubbs Trees don't grow to the sky. You are a clown supporting a bubble. Walk away. This is an insanity bubble. Get a real job kid. Salary cap is the only solution.The sport needs a [--] year hiatus to reset the table. PS Get some balance in your life. We are all here on a borrow"  
[X Link](https://x.com/TheNorthStar5/status/2012135712775373286)  2026-01-16T12:11Z [---] followers, [--] engagements


"$ACTU @ActuateThera $IBB $XBI (1/3) It's the home stretch for [----] already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK https://t.co/QXylsdCM94 (1/3) It's the home stretch for [----] already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK"  
[X Link](https://x.com/TheNorthStar5/status/1973803607033327723)  2025-10-02T17:33Z [---] followers, [---] engagements


"@ToddSullivan @todd_harrison $CRBP $EXAS @RedDogT3 The facts will out. They always do https://www.corbuspharma.com/news/press-releases/detail/260/corbus-pharmaceuticals-announces-agreement-with-fda-on https://www.cff.org/News/News-Archive/2018/CF-Foundation-Awards-Up-to-25-Million-for-the-Development-of-a-Novel-Drug-to-Reduce-Inflammation-in-CF/"  
[X Link](https://x.com/TheNorthStar5/status/1114240011157819401)  2019-04-05T18:54Z [---] followers, [--] engagements


"$ACTU $RVMD $IMRX $IBB $XBI November marks #PancreaticCancerAwarenessMonth. Pancreatic cancer remains one of the most challenging cancers to detect and treat with a 5-year survival rate of just 13%. Elraglusib Actuate's novel GSK-3 inhibitor is currently being studied in a randomized Phase [--] trial https://t.co/pCiQyfpExJ November marks #PancreaticCancerAwarenessMonth. Pancreatic cancer remains one of the most challenging cancers to detect and treat with a 5-year survival rate of just 13%. Elraglusib Actuate's novel GSK-3 inhibitor is currently being studied in a randomized Phase [--] trial"  
[X Link](https://x.com/TheNorthStar5/status/1988326090486788534)  2025-11-11T19:20Z [---] followers, [---] engagements


"$ACTU $IMRX $IBB $XBI $RVMD At Actuate our mission is to give patients with hard-to-treat cancers the opportunity to live longer & better with the potential capacity to slow stop or shrink tumors with minimal adverse effects. This #PancreaticCancerAwarenessMonth we reaffirm our commitment. https://t.co/F4ZlbqbiJr At Actuate our mission is to give patients with hard-to-treat cancers the opportunity to live longer & better with the potential capacity to slow stop or shrink tumors with minimal adverse effects. This #PancreaticCancerAwarenessMonth we reaffirm our commitment."  
[X Link](https://x.com/TheNorthStar5/status/1991159606173659514)  2025-11-19T15:00Z [---] followers, [---] engagements


"$ACTU @ActuateThera @lustgartenfdn $IMRX 🚀Episode #3 of The Upside is live Pancreatic cancer remains one of the hardest deadliest cancers to treat. But $ACTUs lead drug has shown meaningful improvements in survival and could be the start of a true pipeline in a molecule. With major regulatory + clinical https://t.co/Am4WODLFeh 🚀Episode #3 of The Upside is live Pancreatic cancer remains one of the hardest deadliest cancers to treat. But $ACTUs lead drug has shown meaningful improvements in survival and could be the start of a true pipeline in a molecule. With major regulatory + clinical"  
[X Link](https://x.com/TheNorthStar5/status/1996268666761969737)  2025-12-03T17:21Z [---] followers, [---] engagements


"$ACTU $IBB $XBI $RVMD $IMRX @lustgartenfdn Good backgrounder on the @ActuateThera story by CEO Dan Schmitt Actuate Therapeutics President and CEO Dan Schmitt was recently featured by @AlexWestchester in @GENbio spotlighting the potential progress of elraglusib in metastatic pancreatic cancer and the ongoing Actuate-1801 trial. https://t.co/UR6s3WV6M3 #Cancer #PancreaticCancer https://t.co/NFge2Abv4P Actuate Therapeutics President and CEO Dan Schmitt was recently featured by @AlexWestchester in @GENbio spotlighting the potential progress of elraglusib in metastatic pancreatic cancer and the"  
[X Link](https://x.com/TheNorthStar5/status/1998812584838070515)  2025-12-10T17:50Z [---] followers, [---] engagements


"$ACTU $IBB $XBI $RVMD $IMRX @LouBasenese On The Bio Report @ActuateThera CEO Dan Schmitt joins @dslevine to discuss elraglusib a GSK3 inhibitor that targets chemoresistance and helps re-activate anti-tumor immunity in hard-to-treat solid tumors. Listen: https://t.co/lm0EJkOpkG $ACTU #PancreaticCancer #Oncology https://t.co/jmbotINuoY On The Bio Report @ActuateThera CEO Dan Schmitt joins @dslevine to discuss elraglusib a GSK3 inhibitor that targets chemoresistance and helps re-activate anti-tumor immunity in hard-to-treat solid tumors. Listen: https://t.co/lm0EJkOpkG $ACTU #PancreaticCancer"  
[X Link](https://x.com/TheNorthStar5/status/2001481198544261628)  2025-12-18T02:34Z [---] followers, [---] engagements


"$ACTU $IBB $XBI $RVMD $IMRX @LouBasenese .@ActuateThera will present new Phase [--] data for elraglusib + gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer at the #2026 @ASCO GI Cancers Symposium in #SanFrancisco. Devalingam Mahalingam MD PhD from @NUFeinbergMed will present. For more: https://t.co/y02hSfA7BK .@ActuateThera will present new Phase [--] data for elraglusib + gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer at the #2026 @ASCO GI Cancers Symposium in #SanFrancisco. Devalingam Mahalingam MD PhD from @NUFeinbergMed will present. For more:"  
[X Link](https://x.com/TheNorthStar5/status/2001712264983019724)  2025-12-18T17:52Z [---] followers, [---] engagements


"@DZalkowitz @TheHunter5515 @BioWorld @CorbusPharma David . go back in the sand box with your Fake News. $ talks. Bull sh$t walks https://globenewswire.com/news-release/2019/01/03/1680241/0/en/Corbus-Pharmaceuticals-Announces-Strategic-Collaboration-with-Kaken-Pharmaceutical-Co-Ltd-to-Develop-and-Commercialize-Lenabasum-in-Japan-for-Systemic-Sclerosis-and-Dermatomyositis.html https://www.cff.org/News/News-Archive/2018/CF-Foundation-Awards-Up-to-25-Million-for-the-Development-of-a-Novel-Drug-to-Reduce-Inflammation-in-CF/"  
[X Link](https://x.com/TheNorthStar5/status/1085326913110007809)  2019-01-16T00:04Z [---] followers, [--] engagements


"$crbp Will someone forward these articles to the ambulance chaser law firms citing an anonymous short seller screaming fire from earlier [----] trials now in registration trials https://www.corbuspharma.com/news/press-releases/detail/260/corbus-pharmaceuticals-announces-agreement-with-fda-on https://www.globenewswire.com/news-release/2019/01/03/1680241/0/en/Corbus-Pharmaceuticals-Announces-Strategic-Collaboration-with-Kaken-Pharmaceutical-Co-Ltd-to-Develop-and-Commercialize-Lenabasum-in-Japan-for-Systemic-Sclerosis-and-Dermatomyositis.html"  
[X Link](https://x.com/TheNorthStar5/status/1106024529632083968)  2019-03-14T02:49Z [---] followers, [--] engagements


"$ACTU @ActuateT $XBI $IBB ICYMI Statistical Significance Met on Primary Endpoints of [--] Year Survival Rate and Median Overall Survival https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/ https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/"  
[X Link](https://x.com/TheNorthStar5/status/1871244526305542604)  2024-12-23T17:20Z [---] followers, [---] engagements


"@Opal_Chip @SteveYonezu @ErikOtto2 @Biomaven @bs2537 Do you know Mike Moyer of Lifesci(see bottom of PR). I would contact him to get the Lucid initiation and follow up notes. Excellent backgrounder $ACTU https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/ https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/"  
[X Link](https://x.com/TheNorthStar5/status/1882116168292667805)  2025-01-22T17:20Z [---] followers, [---] engagements


"$ACTU $IBB $XBI Someone will wake up soon on @ActuateT Very soon [--] weeks or so we should have a $2 or $3 in front of a double digit stock and eventually a $5 or $6 in front of a double digit stock. Stay tuned for final top line data in late March. WTFU https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/"  
[X Link](https://x.com/TheNorthStar5/status/1886475413821550855)  2025-02-03T18:02Z [---] followers, [---] engagements


"$ACTU $IBB $XBI Expecting topline data on randomized Phase [--] trial of elraglusib in combination withgemcitabine/nab-paclitaxel (GnP) in first line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) (Actuate-1801 Part 3B) in early APRIL 🔥🔥 https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/"  
[X Link](https://x.com/TheNorthStar5/status/1894820527228805387)  2025-02-26T18:43Z [---] followers, [----] engagements


"$ACTU It won't be long now folks. Best guess is top line data next week on @ActuateThera Phase [--] data. This could get real exciting.Must be in it to win $IBB $XBI @unusual_whales @semodough $CRDF @Opal_Chip $RVMD @Maximus_Holla @ripster47 No skin no win https://actuatetherapeutics.com/press_releases/actuate-therapeutics-announces-positive-interim-phase-2-data-of-elraglusib-in-first-line-treatment-of-metastatic-pancreatic-cancer/"  
[X Link](https://x.com/TheNorthStar5/status/1912151651357512118)  2025-04-15T14:30Z [---] followers, [----] engagements


"$ACTU @ActuateThera Actuate Therapeutics to Host KOL Event on Topline Phase [--] Data of Elra at "ASCO Saturday" plenary session $RVMD $IBB $XBI @BioStocks @BiotechCH @Maximus_Holla @semodough @Biomaven $GILD @Opal_Chip @bs2537 $QQQ Read between the lines https://actuatetherapeutics.com/press_releases/actuate-therapeutics-to-host-kol-event-on-topline-phase-2-data-of-elraglusib-in-metastatic-pancreatic-ductal-adenocarcinoma-during-asco-annual-meeting/"  
[X Link](https://x.com/TheNorthStar5/status/1920093002967498967)  2025-05-07T12:27Z [---] followers, [---] engagements


"Craih Hallum note on $ACTU @ActuateThera $RVMD $IBB $XBI $RUT @Maximus_Holla @d4ytrad3 @BPharmCatalyst Actuate Therapeutics Inc. (ACTU) We Maintain Our Conviction Behind Elraglusib's Potential In 1L mPDAC And Remain Buyers Ahead Of Topline Phase II Data To Be Presented At ASCO"  
[X Link](https://x.com/TheNorthStar5/status/1925544005023981613)  2025-05-22T13:27Z [---] followers, [---] engagements


"$ACTU @ActuateT Impeccable ASCO data Company plans to engage with FDA in the second half of [----] to align on a path towards product registration- My guess is Breakthrough designation is next up $IBB $XBI $RVMD @BioStocks @Maximus_Holla @semodough $GILD https://actuatetherapeutics.com/press_releases/actuate-therapeutics-presents-topline-elraglusib-phase-2-data-at-asco-2025-annual-meeting-trial-meets-primary-endpoint-of-median-overall-survival-and-doubles-1-year-survival-in-first-line-treatment-o/"  
[X Link](https://x.com/TheNorthStar5/status/1928933350762246633)  2025-05-31T21:55Z [---] followers, [---] engagements


"$ACTU @ActuateThera $IBB $XBI $RVMD See Chris Liu comment in this article- Huge https://prismmarketview.com/actuate-therapeutics-doubles-1-year-survival-in-metastatic-pancreatic-cancer-with-elraglusib-phase-2-data-unveiled-at-asco-2025/ https://prismmarketview.com/actuate-therapeutics-doubles-1-year-survival-in-metastatic-pancreatic-cancer-with-elraglusib-phase-2-data-unveiled-at-asco-2025/"  
[X Link](https://x.com/TheNorthStar5/status/1929527135749710148)  2025-06-02T13:14Z [---] followers, [---] engagements


"$ACTU @ActuateThera $RVMD $IBB $XBI $GILD $BMY $IMRX $MRK https://www.accessnewswire.com/newsroom/en/biotechnology/actuate-therapeutics-advances-a-new-era-in-oncology-with-potential-universal-backbone-1064578 https://www.accessnewswire.com/newsroom/en/biotechnology/actuate-therapeutics-advances-a-new-era-in-oncology-with-potential-universal-backbone-1064578"  
[X Link](https://x.com/TheNorthStar5/status/1960067986884067672)  2025-08-25T19:53Z [---] followers, [---] engagements


"B. Riley initiates $ACTU @ActuateThera Actuate Therapeutics with a $20 TP @BioStocks @Maximus_Holla $IBB $XBI $RVMD $GILD $BMY $MRK @PanCAN @ripster47 @RNAiAnalyst @Alexand80831564 @PanCAN @joealertz $IMRX"  
[X Link](https://x.com/TheNorthStar5/status/1960303491101884739)  2025-08-26T11:29Z [---] followers, [---] engagements


"https://www.tipranks.com/news/the-fly/actuate-therapeutics-initiated-with-a-buy-at-b-riley-thefly https://www.tipranks.com/news/the-fly/actuate-therapeutics-initiated-with-a-buy-at-b-riley-thefly"  
[X Link](https://x.com/TheNorthStar5/status/1960306414280134691)  2025-08-26T11:40Z [---] followers, [--] engagements


"$ACTU @ActuateThera B Riley initiation on Actuate with $20 TP @BioStocks @joealertz $IBB $XBI https://www.tipranks.com/news/the-fly/actuate-therapeutics-initiated-with-a-buy-at-b-riley-thefly https://www.tipranks.com/news/the-fly/actuate-therapeutics-initiated-with-a-buy-at-b-riley-thefly"  
[X Link](https://x.com/TheNorthStar5/status/1960306851871912357)  2025-08-26T11:42Z [---] followers, [---] engagements


"$ACTU $IBB $XBI @ActuateThera $RVMD $IMRX 🚨 VOSS CAPITAL DISCLOSES NEW 5.3% PASSIVE STAKE IN ACTUATE THERAPEUTICS 🚨 🏢 COMPANY INFORMATION Company: ACTUATE THERAPEUTICS INC. $ACTU Form Type: SCHEDULE 13G Filing Date: 12/17/2025 Trading Significance: High 👤 INSIDER DETAILS Name: Voss Capital LP 🚨 VOSS CAPITAL DISCLOSES NEW 5.3% PASSIVE STAKE IN ACTUATE THERAPEUTICS 🚨 🏢 COMPANY INFORMATION Company: ACTUATE THERAPEUTICS INC. $ACTU Form Type: SCHEDULE 13G Filing Date: 12/17/2025 Trading Significance: High 👤 INSIDER DETAILS Name: Voss Capital LP"  
[X Link](https://x.com/TheNorthStar5/status/2001346535356010710)  2025-12-17T17:39Z [---] followers, [---] engagements


"$APRE I paid .93 last week"  
[X Link](https://x.com/anyuser/status/2003145243152253029)  2025-12-22T16:46Z [---] followers, [--] engagements


"$ACTU Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt $IBB $XBI @LouBasenese $RVMD $IMRX https://www.youtube.com/watchv=z9l1E9oU_Nw https://www.youtube.com/watchv=z9l1E9oU_Nw"  
[X Link](https://x.com/anyuser/status/2003822789481124162)  2025-12-24T13:39Z [---] followers, [---] engagements


"$KZIA See page 36-48 for the list of investors in the recent @KaziaTx $5 private placement. Even Point [--] bought 200k shares @Maximus_Holla $XBI $IBB @DanCarlson33 https://www.sec.gov/Archives/edgar/data/1075880/000119312525331158/d45363d424b3.htm#tx45363_11 https://www.sec.gov/Archives/edgar/data/1075880/000119312525331158/d45363d424b3.htm#tx45363_11"  
[X Link](https://x.com/anyuser/status/2006451036421238914)  2025-12-31T19:42Z [---] followers, [---] engagements


"Write it down @StevenACohen2 @Maximus_Holla @PeterKolchinsky @Varro_Analytics @ripster47 @sharkbiotech The Kazia @KaziaTx $KZIA is going much higher here folks. $IBB $XBI"  
[X Link](https://x.com/anyuser/status/2008919085510181067)  2026-01-07T15:10Z [---] followers, [---] engagements


"$ACTU $RVMD $IMRX $IBB $XBI .@ActuateThera is featured on the cover of @CCR_AACR (Vol. [--] Issue 1) an @AACR publication. The cover image shows a tumor biopsy section from a patient with acinic cell carcinoma (parotid gland). Immunohistochemical staining highlights aberrant nuclear and cytoplasmic https://t.co/8rV49Yfo4v .@ActuateThera is featured on the cover of @CCR_AACR (Vol. [--] Issue 1) an @AACR publication. The cover image shows a tumor biopsy section from a patient with acinic cell carcinoma (parotid gland). Immunohistochemical staining highlights aberrant nuclear and cytoplasmic"  
[X Link](https://x.com/anyuser/status/2009101781096386732)  2026-01-08T03:16Z [---] followers, [---] engagements


"$KZIA's paxalisib is an oral version of a brain penetrant inhibitor of the PI3K/Akt/mTor pathway while the $CELC version is an IV. Juxtapose the valuation gap $CELC $5 billion vs $KZIA $75 million with $45 mill in cash. You get Phase [--] GBM program for free. Smart $ in $XBI $IBB Interesting that nobody seems to be talking about how $KZIA has effectively the same drug as $CELC but with BBB penetration. No surprise $CELC went after the bigger HR+/HER2- market but given the Phase [--] results they had in TNBC if $KZIA can replicate those we have a 10x here Interesting that nobody seems to be talking"  
[X Link](https://x.com/anyuser/status/2009261851427643848)  2026-01-08T13:52Z [---] followers, [---] engagements


"$KZIA Read this closely. Free $ on @KaziaTx from here. This is a finger roll. $IBB $XBI @Maximus_Holla Buy buy buy and when you are done buy it again @StevenACohen2 @ripster47 @semodough @Varro_Analytics @BioStocks https://www.prnewswire.com/news-releases/kazia-therapeutics-to-participate-in-jp-morgan-healthcare-conference-week-clinical-and-translational-update-anticipated-before-month-end-302656513.html https://www.prnewswire.com/news-releases/kazia-therapeutics-to-participate-in-jp-morgan-healthcare-conference-week-clinical-and-translational-update-anticipated-before-month-end-302656513.html"  
[X Link](https://x.com/anyuser/status/2009269946077847572)  2026-01-08T14:24Z [---] followers, [---] engagements


"Pure thuggery is humbled: Philly fans classless as usual https://x.com/MLFootball/status/2010474448076624016 Nobody needed to be humbled at home more than the #Eagles and their fans https://t.co/6q3KG7rLIS https://x.com/MLFootball/status/2010474448076624016 Nobody needed to be humbled at home more than the #Eagles and their fans https://t.co/6q3KG7rLIS"  
[X Link](https://x.com/TheNorthStar5/status/2010529663517688045)  2026-01-12T01:50Z [---] followers, [--] engagements


"$KZIA @KaziaTx is ready to break out from the $7 level with data readout in next [--] weeks. It's trading like a dawg in heat. $IBB $XBI @Maximus_Holla Incremental beast cancer data this month. Double digits probable"  
[X Link](https://x.com/anyuser/status/2012151759620493705)  2026-01-16T13:15Z [---] followers, [---] engagements


"$KZIA News next week. Stock should get some nice wheels"  
[X Link](https://x.com/anyuser/status/2014352747928117579)  2026-01-22T15:01Z [---] followers, [---] engagements


"$KZIA @KaziaTx $IBB $XBI Next week. Do the math $KZIA @KaziaTx is ready to break out from the $7 level with data readout in next [--] weeks. It's trading like a dawg in heat. $IBB $XBI @Maximus_Holla Incremental beast cancer data this month. Double digits probable $KZIA @KaziaTx is ready to break out from the $7 level with data readout in next [--] weeks. It's trading like a dawg in heat. $IBB $XBI @Maximus_Holla Incremental beast cancer data this month. Double digits probable"  
[X Link](https://x.com/anyuser/status/2014353635279360422)  2026-01-22T15:05Z [---] followers, [---] engagements


"$KZIA ICYMI THIS WEEK NOW @KaziaTx $IBB $XBI @Maximus_Holla $KZIA @KaziaTx $IBB $XBI Next week. Do the math $KZIA @KaziaTx $IBB $XBI Next week. Do the math"  
[X Link](https://x.com/anyuser/status/2015808057452744784)  2026-01-26T15:24Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing